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Abstract
Antagonistic interactions are likely important driving forces of the evolutionary process underlying bacterial genome
complexity and diversity. We hypothesized that the ability of evolved bacteria to escape specific components of host innate
immunity, such as phagocytosis and killing by macrophages (MW), is a critical trait relevant in the acquisition of bacterial
virulence. Here, we used a combination of experimental evolution, phenotypic characterization, genome sequencing and
mathematical modeling to address how fast, and through how many adaptive steps, a commensal Escherichia coli (E. coli)
acquire this virulence trait. We show that when maintained in vitro under the selective pressure of host MW commensal E.
coli can evolve, in less than 500 generations, virulent clones that escape phagocytosis and MW killing in vitro, while
increasing their pathogenicity in vivo, as assessed in mice. This pathoadaptive process is driven by a mechanism involving
the insertion of a single transposable element into the promoter region of the E. coli yrfF gene. Moreover, transposition of
the IS186 element into the promoter of Lon gene, encoding an ATP-dependent serine protease, is likely to accelerate this
pathoadaptive process. Competition between clones carrying distinct beneficial mutations dominates the dynamics of the
pathoadaptive process, as suggested from a mathematical model, which reproduces the observed experimental dynamics
of E. coli evolution towards virulence. In conclusion, we reveal a molecular mechanism explaining how a specific component
of host innate immunity can modulate microbial evolution towards pathogenicity.
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Introduction
Bacteria can be used to study evolution in real time in controlled
environments, i.e. experimental evolution [1]. Different studies have
demonstrated that bacterial populations have an enormous
potential to adapt to relatively simple abiotic challenges under
laboratory environments [2,3]. On the other hand, far less is known
on how biotic interactions shape bacterial adaptive evolution.
Antagonistic interactions (predation, parasitism) are likely to be
important determinants of the rate of adaptive change observed in
bacteria, their trait diversity and genome complexity [4,5,6]. The
best-studied antagonistic interaction in an evolutionary laboratory
setting is the one involving bacteria and their phages, which
increases rates of bacterial adaptation and diversification [7,8],
demonstrating that biotic interactions can have an important role in
bacterial evolution [9]. Another common antagonistic interaction
faced by bacteria occurs when these infect mammals and are
directly exposed to cells of the host immune system. To our
knowledge this interaction has never been addressed in an
experimental evolution context. Here, we determined the mecha-
nisms via which E. coli evolve to overcome the antagonistic
interaction imposed by one of the central components of host
innate immunity, namely monocyte/macrophages (MW).
E. coli is both a commensal and a versatile pathogen, acting as a
major cause of morbidity and mortality worldwide [10]. More-
over, there is evidence that some pathogenic E. coli evolved from
commensal strains [11,12], making E. coli an ideal organism to
study the transition from commensalism to pathogenicity. E. coli
colonizes the infant gastrointestinal tract within hours after birth,
and typically builds a mutualistic relation. However, non-
pathogenic strains of E. coli can become pathogenic, when the
gastrointestinal barrier is disrupted as well as in immunosup-
pressed hosts [13,14,15].
MW are a key component of host defense mechanisms against
pathogens [16]. They can provide direct bactericidal response
through phagocytosis, a process by which bacteria are killed inside
endocytic phagosomes, through the generation of reactive oxygen
and nitrogen species among other effector mechanisms. Yet many
bacterial species are capable to escape and resist eukaryotic cells
[17,18], suggesting that several bacterial defense mechanisms
evolve upon encounter with MW. Adaptive microbial mechanisms
to escape MW include surface masking and capsule formation (to
avoid engulfment and phagocytosis), increased motility, filamenta-
tion and biofilm formation. Mechanisms acting after engulfment
by MW include toxin release. Within the species of E. coli alone,
there are examples of several different mechanisms [19].
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In the present study, we established an in vitro system in which E.
coli is allowed to evolve under continuous selective pressure of MW,
and ask how quickly and by which mechanisms commensal E. coli
evolve resistance to one of the sentinels of the innate immune
system, the MW.
Results
Emergence of morphological diversity and dynamics of
phenotypes
We followed the evolution of six E. coli populations (all founded
from the same ancestral clone), when adapting to the antagonistic
interaction imposed by the murine monocytic cell line (RAW
264.7), referred throughout the text as MW. The bacterial
populations (M1 to M6) evolved, by serial passage, in complete
culture medium with MW and were propagated at a multiplicity of
infection (MOI) of 1:1 (106 E. coli to 106 MW, see Fig. S1). After
24 hours bacterial numbers reach around 46108 and are
subsequently bottlenecked to start the next passage with 106
bacteria again. In parallel, we also evolved E. coli under identical
experimental conditions in the absence of MW (the resulting
evolved clones are named CON). In this case the population is
propagated by daily passages involving a bottleneck of 104 cells at
each passage. This results in ,15 generations per day, given the
increase in bacteria numbers observed during 24 hours. All
populations evolved for a period of 30 days, which corresponds
to approximately 450 generations. We note that this is an
approximate value because as adaptation proceeds the population
dynamics will change and differences in the number of generations
per day will occur.
Adaptation of the bacterial lines in the presence of MW was
characterized by the emergence of phenotypic variation within
populations. After 4 days of evolution, i.e. approximately 60
generations, distinct colony morphologies emerged in all popula-
tions, detected when plating on LB plates (Fig. 1A). Such
morphological diversity was never observed in control populations
evolved for 30 days under the same experimental conditions in the
absence of MW (n = 6). Two distinct heritable morphs were
identified and scored, i.e. small colony variants (SCV) and large
translucid mucoid (MUC) colonies and their frequencies were
quantified over time (Fig. 1B). SCVs were observed in five out of
six populations, but this morph remained at low frequency and
was only detected transiently. The parallel emergence of SCVs in
independent evolving populations, suggests that this phenotype
constitutes an initial adaptation of E. coli to the antagonistic
interaction imposed in vitro by MW. In contrast, MUC clones
which rose in frequency in all populations, reached fixation in five
out of six populations by day 30. The changes in frequency of
SCVs and MUCs showed complex dynamics (Fig. 1B). In some
populations, once SCVs decreased in frequency MUCs tended to
increase, e.g. populations M2 and M3. This suggests that MUCs
can outcompete SCVs, presumably due to a larger fitness
advantage. These observations suggest that E. coli morphological
diversity can emerge very rapidly as a result of their adaptation to
MW.
Fitness increase and phenotypic characterization of SCV
and MUC clones
Competitive fitness of E. coli populations was measured at two
time points during the process of evolution (day 19,285
generations and day 30,450 generations), revealing that all
populations exhibit a significant fitness increase (Fig. 2A). On
average, fitness increase was of 0.10 (2SE= 0.07) and 0.27
(2SE= 0.10) after 19 and 30 days, respectively. Fitness increased
between generations 285 and 450 across populations (Students’
paired t-Test, P = 0.02).
The observation that SCVs emerged in at least 80% of the
independent evolving populations but with low frequency strongly
suggests that SCVs have a transient selective advantage that is
outcompeted over time. To better understand this selective
advantage we performed two assays: 1) exposure of MW in vitro
to SCVs to test for possible intracellular versus extracellular
growth differences relative to that of the ancestral strain; 2) a
fitness assay to determine the ability of SCV to outcompete the
ancestral strain, in the presence of MW. We did not observe any
difference in SCV growth either intracellularly (Rr = 0.99+0.16
(2SE)) or extracellularly (Rr = 1.01+0.13 (2SE)) relative to the
ancestral non-evolved clone, while there was an advantage in the
competitive fitness assay (Fig. 2B). SCVs (clones SCV_M1_D8 and
SCV_M3_D5) exhibited a fitness advantage relative to the
ancestral strain, inside MW, as assayed 2 hours after infection.
However, this advantage was restricted to the early phase of
infection, given that SCVs showed a disadvantage outside MW
24 hours after infection (Fig. 2B). These results probably explain
why SCVs increased in frequency but failed to reach fixation (see
Fig. 1B).
We tested the in vitro evolved SCVs for traits common to those of
clinical SCV isolates from different bacterial species [20] [21]. The
evolved E. coli SCVs showed an increased resistance to aminogly-
cosides, but not to other antibiotics (see Supplemental Table S1),
were catalase negative and showed a remarkable instability. In rich
medium SCVs reverted to a large colony phenotype at a frequency
of 961024 (2SE= 461024) and supplementation with hemin
enhanced their growth relative to the ancestral (SCV_M1_D8:
2.961 (2SE) and SCV_M3_D5: 2.560.7(2SE)). These results
imply that the selective pressure of MW led to the emergence of
phenotypes typical of pathogenic bacteria.
Mucoidy, the trait evolved in the MUC clones, is also a trait
observed in certain infections, for example in Pseudomonas aeruginosa
or E. coli [22,23]. The in vitro evolved MUCs produce high levels of
exopolysaccharides when plated on LB. Since colanic acid is
present in most natural E. coli isolates [24], and this capsule is
made in mutants of E. coli that emerge under stress conditions
[25], we tested mucoid clones for overproduction of this
exopolysaccharide. Mucoid clones showed overproduction of
colanic acid (Fig. 2C, Fig. S2), suggesting that rapid evolution to
change this trait can occur under the specific selection pressure
imposed by MW. We tested whether MUCs escaped MW
engulfment, by quantifying the relative abundance of intracellular
and extracellular of MUC after 3 hours co-incubation with MW.
Author Summary
The selective pressure imposed by the host immune
system is an important component of microbial adaptation
from commensalism to pathogenicity. We used experi-
mental evolution to study the initial steps of the
adaptation of Escherichia coli to cells of the innate immune
system, i.e., macrophages. Our results demonstrate that
bacteria can evolve remarkably fast, and acquire adapta-
tions increasing survival inside macrophages and/or ability
to escape engulfment. The mechanism underlying this
pathoadaptive process involves the accumulation of
mutations caused by transposon insertions, increasing
pathogenicity in vivo. These findings reveal the remarkable
fast pace at which bacteria can evolve to escape a central
component of the host innate immunity, namely macro-
phages.
E. coli Adaptation to Macrophages
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Relative abundance of intracellular bacteria in MW was lower for
MUC versus the ancestral strain in 6 out of 6 MUC clones tested
(Fig. 2D). Moreover, the extracellular abundance of MUC clones
relative to ancestral was higher in 4 out of 6 MUCs tested. We
then asked whether MUCs would trigger MW cytotoxicity, a
process that would contribute to reduce the negative impact
exerted by MW on MUC versus ancestral clones. MW cytotoxicity
was similar in the presence of MUC versus ancestral clones
Figure 1. Emergency of morphological diversity in the bacterial populations adapting to MW. (A) Examples of the variability for colony
morphology that emerged in E. coli populations adapting to MW, from left to right – ANC stands for morphology of ancestral, SCV for the small colony
variants morphology and MUC for the mucoid colony morphology. (B) Dynamics of frequency change of the evolved phenotypes in each replicate
evolving populations (M1 to M6): white squares indicate ANC, black triangles SCV, black circles MUC phenotypes.
doi:10.1371/journal.ppat.1003802.g001
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(Fig. S3A and Fig. S3B). Furthermore MUCs did not cause any
significant changes in MW ability to engulf the ANC clone (Fig.
S3C). Taken together, these results strongly suggest that MUCs
are better adapted to escape MW but do not diminish the ability of
MW to internalize ancestral E. coli.
E. coli evolved in vitro to escape MW show increased
virulence in vivo
We tested whether adaptation of evolved MUC clones to escape
MW is associated with increased virulence. We compared the
survival of mice infected systemically via the intra-peritoneal route,
with increasing amounts of MUC versus ANC bacteria or bacteria
that evolved in the absence of MW (CON) (Fig. 3A). The lethal
dose 50 (LD50) of MUC infection (LD50: 2.8610
7, with 95% CI
1.46107–5.86107) was 5–10 times lower than that of ANC (LD50:
1.66108, with 95% CI 8.56107–2.86108) or CON (LD50: above
16108), as inferred from the confidence intervals (Fig. 3A and 3B),
suggesting that MUC clones have increased virulence. In
agreement with these observations, infection with ancestral or
with bacteria evolved in the absence of MW at a dosage
corresponding to the MUC LD50 was not lethal, i.e., 100%
survival of mice occurred (log-rank test: x22 = 9.9, p=0.007;
Fig. 3C). Higher lethality of MUC infection was associated with
significant reduction in temperature (but not weight), as compared
Figure 2. Phenotypic characterization of evolved populations. (A) Fitness increase of M1 to M6 populations relative to the ancestral clone at
285 (white bars) generations and 450 (black bars) generations. Error bars correspond to 2SE. (B) Competitive fitness of SCV clones in presence of MW.
The change in frequency (DX) of the evolved bacteria against the ancestral in the intracellular (black bars) and extracellular (white bars) niche of the
MW at MOI (1:1). Clones are ranked in the following order: SCV_M1_D8 and SCV_M3_D5. Because SCV clones revert to ancestral looking colonies,
frequencies of those phenotypic revertant SCV_REV colonies are shown in grey. (C) MUC clones overproduce colanic acid. After purification from the
growth medium of each clone (SCV_M1_D8, MUC_M3_D19 and ANC), the amount of colanic acid was determined by measuring non-dialyzable
methylpentose (fucose) absorbance at 396 and 427 nm after reaction with sulfuric acid and cysteine hydrochloride. Measurements were repeated
three times for each clone. Obtained values (DA396–DA427) were directly correlated with fucose calibration curve (see Fig. S2) and normalized for
CFUs. (D) Evidence that MUC clones adapted to better escape MW phagocytosis. Rr represents the relative abundance (Rr) of evolved clones to that of
the ancestral at 3 h of infection. Clones MUC1 to MUC6 were sampled from each independent evolution. In black bars the relative abundance inside
MW and in white bars outside MW. All evolved clones show a smaller abundance inside MW, suggesting that these are better adapted to escape MW
phagocytosis. Error bars correspond to 2SE.
doi:10.1371/journal.ppat.1003802.g002
E. coli Adaptation to Macrophages
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to infection with ANC bacteria at the dosage corresponding to the
MUC LD50 (x
2
2 = 0.61, p=0.0004; Fig. 3D).
We then asked whether MUC bacteria elicited a MW response
in vitro that would be somehow altered, as compared to the
response elicited under the same conditions by the ANC or CON
clones. When co-cultured with MUC, primary mouse peritoneal
MW produced similar levels of the pro-inflammatory cytokine
TNF, as compared to MW co-culture with ANC or CON clones
(see Text S1 and Fig. S4). This suggest that although MUC clones
have evolved to escape MW in vitro and increasing their
pathogenicity in vivo, these clones are still readily detected by
MW, as revealed by TNF secretion. This read out was used hereby
as out-put of pattern recognition receptor triggered signaling
leading to the activation of a core pro-inflammatory signal
transduction pathway, which appears to be equally responsive to
the different bacterial clones tested.
Overall our results show that the MUC clones, which
overproduce colanic acid and dominated the bacteria populations
during the interaction with MW, exhibit increased virulence.
Genetic basis of the adaptation to macrophages
Given the phenotypes of the MUCs and their dynamics, we
sought to determine the molecular basis of the mutations
responsible for their increase in frequency along the evolutionary
process. Whole genome sequencing of a clone sampled from M3
population at day 19 of the evolution process (MUC_M3_D19)
revealed that it carries two transposon insertions, i.e. a IS186
insertion into the promoter region of lon and one IS1 insertion
upstream of the yrfF gene (see Table 1). The IS1 insertion event
occurred in all sequenced clones sampled at day 30 (Table 1,
Fig. 4A), revealing parallelism at the genetic level across all
independently evolved lines. The function of the yrfF gene is
unknown in E. coli, but its homologue in Salmonella, i.e. igaA,
prevents over-activation of the Rcs regulatory system, which
regulates colanic acid capsule synthesis [26]. It is therefore likely
that the insertion upstream of yrfF alters E. coli ability to produce
colanic acid, in keeping with the observation that MUC clones
produce high levels of colanic acid, as compared to ANC bacteria
(Fig. 2C).
Figure 3. In vitro evolved E. coli show increased virulence in vivo. A) Survival of mice infected with different doses of ancestral (ANC, in blue),
mucoid bacteria evolved in the presence of MW (MUC, in red) or bacteria evolved in the absence of MW (CON, in green). The number of mice are
shown inside the bars, B) Survival probability of mice infected with ANC, MUC and CON, represented as lines from the fit of a binomial General Linear
Model used to infer LD50, C) Kaplan-Meier curves and D) % maximum reduction in temperature or weight at the LD50 dose for the MUC (n = 10), ANC
(n = 11) and CON (n = 5) (Error bars correspond to 2SE, * indicates p,0.05).
doi:10.1371/journal.ppat.1003802.g003
E. coli Adaptation to Macrophages
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Other important parallelisms (observed in 3 out of 6 populations
analyzed) include two transposition events, namely, one in yiaW
coding region and the other in the coding region of the pot operon.
potD is one of the four genes of the potABCD operon, a spermidine-
preferential uptake system [27]. All four genes are essential for
spermidine uptake, indicating that the insertions in potD detected
in clones MUC_M4_D30 and MUC_M6_D30, or the insertion in
potA observed in clone MUC_M3_D30, are likely to impair uptake
of spermidine. We tested the effect of polyamines in the evolved
MUC clones and observed that while all exhibit a growth
advantage in the presence of spermidine, the clones with insertions
in potD (MUC_M4_D30 and MUC_M6_D30) exhibit an
increased growth advantage compared to the other MUC and
the ancestral, in the presence of spermine (Fig. S5). During
adaptation to MW, insertion in yiaW (whose function is unknown)
was followed rapidly by insertion in potA or potD genes (see Fig. 4B,
M3, M4 and M6 populations), indicating a potential interaction
between these two events. This parallelism was observed in
populations exposed to MW and not in bacteria that evolved in the
absence of MW, suggesting that insertions in yiaW contribute
functionally to adaptation of E. coli to MW. Given that many of the
adaptive mutations observed under the different forms of stress
imposed by MW were caused by IS insertions, we tested if the
frequency of spontaneous mutations (including IS insertions) is
higher in the presence versus absence of MW in the ancestral
strain. No significant differences were found, suggesting that
selection was the main force driving the increase in frequency of IS
elements (see Text S1 and Fig. S6).
Other parallelisms were observed at the level of point mutations
in two clones with the same non-synonymous SNP in fusA, a gene
coding for elongation factor G, which catalyzes the elongation and
recycling phases of translation [28]. Mutations in fusA reduce the
rate of protein synthesis, a hallmark of stress responses, with
pleiotropic effects on bacterial physiology [29]. Mutations in fusA
have also been related with the development of SCVs in S. aureus
[30]. We sequenced fusA in our in vitro evolved E. coli SCVs (11
clones sampled from M1 population at day 8 and 10 clones
sampled at day 4) but did not find any substitutions in this gene.
Dynamics of haplotypes and emergence of a transient
mutator
To further understand the dynamics of adaptation in each
independent evolved bacterial population, we sought to determine
the frequency of the mutations found (see Table 2), in clones
sampled along the evolution experiment. Adaptation involved the
competition between distinct haplotypes and the successive
accumulation of beneficial mutations, mainly caused by IS
insertions (Fig. 4B). Such haplotype dynamics is characteristic of
clonal interference [3], where clones carrying distinct beneficial
mutations compete for fixation. We modeled this process, within
the basic ecological scenario of our experiment (see Fig. 5 and
Text S1, Fig. S7 to S11), fully reproducing the complex dynamics
of the mucoid and non-mucoid phenotypes observed in Figure 1B.
An IS186 insertion into the promoter region of lon, was
observed in clones sampled from populations M3 and M4 (Fig. 4).
Table 1. Mutations acquired by evolved clones identified through whole genome re-sequencing (WGS).
Clone Genome Position Gene Mutation Annotation
MUC_M3_D19 360771 clpX/lon intergenic (+88/2100) IS186 +12 bp
3411601 nudE/yrfF intergenic (2273/247) IS1 +10
MUC1 2029672 yegH GRT A422S GCCRTCC
3356932 fusA ARC S588A TCCRGCC
3411601 nudE/yrfF intergenic (2273/247) IS1 +10
MUC2 3356932 fusA ARC S588A TCCRGCC
3411605 nudE/yrfF intergenic (2277/243) IS1 +6
MUC3 459734 folD/sfmA GRT intergenic (210/2461)
1088154 potA coding (589/1137 nt) IS1 +10
3411601 nudE/yrfF intergenic (2273/247) IS1 +10
3640515 yiaW coding (263/324 nt) IS1 +9
3922002 trkH TRA L389Q CTGRCAG
MUC4 1084946 potD coding (1032/1047 nt) IS1 +9
3411601 nudE/yrfF intergenic (2273/247) IS1 +10
3640515 yiaW coding (263/324 nt) IS1 +9
MUC5 1480525 ydeS/hipA intergenic (21603/+205) D208 bp
2024227 wzc GRT P645T CCGRACG
3411601 nudE/yrfF intergenic (2273/247) IS1 +10
MUC6 1084946 potD coding (1032/1047 nt) IS1 +9
3411601 nudE/yrfF intergenic (2273/247) IS1 +10
3640515 yiaW coding (263/324 nt) IS1 +9
Mutations in intergenic regions have the two flanking genes listed (e.g., clpX/lon). SNPs are represented by an arrow between the ancestral and the evolved nucleotide.
Whenever a SNP gives rise to a non-synonymous mutation the amino acid replacement is also indicated. The symbol D means a deletion. For intergenic mutations, the
numbers in the Mutation row represent nucleotides relative to each of the neighboring genes, here + indicates the distance downstream of the stop codon of a gene
and 2 indicates the distance upstream of the gene, that is relative to the start codon. Insertions of IS elements are denoted by the specific IS element followed by the
number of repeated bases caused by its insertion.
doi:10.1371/journal.ppat.1003802.t001
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Lon (Long Form Filament) is a heat shock protease responsible for
degradation of defective proteins in the cell [31]. The promoter
region of lon is a hotspot for IS186 insertions [31], which may
contribute to the occurrence of this mutation in independently
evolved clones. We tested if the proportion of spontaneous
lon::IS186 mutants is higher in the presence versus absence of
MW, however no difference was observed (see Text S1). As lon
mutants tend to overproduce colanic acid [32], a trait that appears
to be strongly selected for in our experimental system, it is possible
that this was the main beneficial effect caused by the insertion.
However, the IS186 insertion could only be detected at
intermediate time points in the experiment and not at day 30
(see Fig. 4B). Interestingly, lon has been reported to be a mutator
gene in mutants that bear an IS186 insertion in its promoter, thus
increasing the rate of IS transpositions 10- to 100-fold [33]. This
happens because the stability of several transposases is dependent
on the Lon protease [34,35], which seems to regulate their
transposition activity. We tested MUC_M3_D19 for increased
mutagenesis. This clone carries an IS186 inserted in 210
promoter region of lon and since mutations in this position were
shown to significantly decrease level of lon transcription [36], it is
likely that it could be a mutator. If so this could contribute to the
burst of transposition events that occurred during adaptation. We
found a significant increase in the frequency of D-cycloserine
resistant clones in MUC_M3_D19 relative to the ancestral non-
evolved clone (median frequency 2.661026 vs. 161027, for the
ancestral background, P= 5.5610213, W=203.5, Mann-Whitney
U test, Fig. S12). Consistent with this increased mutagenesis being
driven by IS insertions, no significant differences in the frequency
of rifampicin resistant clones, which are caused by point
mutations, were observed (median frequency 3.361027 vs
6.961027 for the ancestral background, P= 0.1, W=21, Mann-
Whitney U test). The presence of IS186 in the lon promoter region
was also found to be highly unstable. A spontaneously derived
non-mucoid clone from MUC_M3_D19 (MUC_M3_D19_REV)
shows a precise excision of this element, while maintaining the IS1
insertion in regulatory region of yrfF (see Table 1). These results
indicate that this IS186 insertion enhances mucoidy levels,
increases mutagenesis and is also very unstable in this genetic
background. The latter may explain why it did not fix in the
populations. The dynamics of the IS186 insertion in populations
M3 and M4 suggest that this mutation was beneficial in the
background with an IS1 insertion upstream of the homologue of
igaA. Support for a selective advantage of this mutation is
suggested by the observation that, in Salmonella, the transcription
of igaA (yrfF in E. coli) is regulated by lon [37].
Discussion
Bacterial evolution towards pathogenicity may occur through
the acquisition of new genes – a gain of function mechanism- or
modification of their current genomes, including loss of genes -
change-of-function mechanism [38]. The later constitutes a
pathoadaptation, in which mutations enhance bacterial virulence
without horizontal transfer of specific genes. For example, the
deletion of hemB in Staphylococcus aureus increases its ability to persist
intracellularly [39] while the loss of mucA increases Pseudomonas
aeruginosa ability to evade phagocytosis and resist to pulmonary
clearance [40].
We followed the evolution of a commensal strain of E. coli under
the selective pressure imposed by MW phagocytosis, to determine
the rate of adaptive evolution and to uncover the nature of possible
E. coli pathoadaptive mutations. From the infection dynamics and
the fitness assays (Fig. 1B and 2), we conclude that at least two
different adaptations, detected by the emergence different colony
morphologies, occurred, namely, i) an intracellular advantage
evolved by SCV clones early in the process; ii) an extracellular
advantage evolved by MUC clones emerging later. The intracel-
lular adaptation is characterized by increased bacterial resistance,
plasticity and survival in the early phase of interaction with MW,
and was accompanied by a reduced extracellular growth. The
extracellular adaptation is associated with overproduction of
colanic acid and characterized by increased resistance to MW
phagocytosis. The functional link between overproduction of
colanic acid and escape from phagocytosis is likely but remains to
be formally established. Overtime this phenotype dominated all
populations.
The mutations acquired by commensal E. coli adapting to MW,
occurred within a few hundred generations and were character-
ized by traits reminiscent of those found in pathogenic bacteria.
Clinical isolates sampled from patients suffering from recurrent
and persistent infections in the blood [41] or urinary tract [21,42],
are SCVs. The distinctive traits of this phenotype are: i) ability to
form small colonies, to revert to larger colony forming bacteria at
high frequencies and ii) increased resistance to certain antibiotics.
In S. aureus SCVs have been implicated as an intermediate form
before mutations in gyrA occur to produce ciprofloxacin resistance
[43]. In addition, Besier et al. have reported thyA mutant S. aureus
SCVs show hypermutator status [44]. These findings suggest that
SCVs could potentiate the emergence of mucoid clones, which
latter go on to dominate the populations. However, we did not
detect in SCVs the mutations found in the mucoid clones,
indicating a distinct molecular basis for the SCV phenotype, an
issue that we will investigate in future work. Given that mucoidy is
also frequently observed in certain infections [22,23], our finding
that this trait can rapidly emerge under the selective pressure of
MW, may have implications not only for the understanding of
host-microbe interactions but also for the treatment of bacterial
infections. Interestingly mucoidy can also be selected by the
pressure imposed by phages in different bacterial species [45,46].
Whether mucoid strains evolved to resist to phages also exhibit
increased virulence remains to be established.
Translocation of commensal E. coli from the gut can be
associated with severe health complications (e.g. sepsis), partic-
ularly in immunosuppressed hosts or after surgery [47,48].
Bacteria that reach the mesenteric lymph nodes or the peritoneal
cavity (extensively populated by MW) and that are able to escape
MW should have a fitness advantage and potentially cause more
Figure 4. Genetic characterization of adaptive mutations and the dynamics of their appearance. (A) Mutations identified in MUC1 to
MUC6 clones isolated from M1 to M6 populations (evolved for 450 generations), represented along the E. coli chromosome. For simplicity, the
genomes are represented linearly and are horizontally drawn. The types of mutations are represented in the following way: SNPs are shown as
crosses, IS insertions as inverted triangles and deletions as triangles. Filled symbols represent mutation in the coding region of the gene and empty
symbols in the regulatory region. (B) Emergence and spread of adaptive mutations in M1 to M6 populations. Dynamics of haplotype frequencies in
evolving populations at different days of evolution experiment are represented by circles. The color and symbol (IS insertions are represented as
circles and other mutations as crosses) of each sector represents different haplotypes and the area of the circle their frequency in the population.
Grey area represents the frequency of clones in the population that were typed for existing mutations in the population and did not differ from
ancestral haplotype.
doi:10.1371/journal.ppat.1003802.g004
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severe disease. Indeed, we found that increased ability to escape
MW of in vitro evolved clones lead to increased pathogenesis in
vivo, when tested in a mouse model. We also found that this
pathoadaptative process was characterized by three main paths.
Although distinct in the number and type of mutations, these
share an initial mutation: an IS insertion upstream of yrfF, a gene
which shares 84% sequence similarity at the protein level to IgaA
of Salmonella enterica serovar Typhimurium. In S. Typhimurium it was
shown that the stability and responsiveness of the RcsCDB system
depends on IgaA [49]. The RcsCDB system controls the
production of colanic acid, virulence in diverse pathogens
[24,50,51,52,53], modulates responses to environmental changes
and is activated upon exposure to antimicrobial peptides
[54,55,56,57]. IgaA represses the RcsCDB system [58] and
mutations causing instability of IgaA activate the RcsCDB
system, leading to overproduction of colanic acid capsule (mucoid
phenotype) [58]. Given the repressive function of IgaA on
RcsCDB, which controls many traits likely to be important for
Table 2. Clones that were typed for existing mutations in M1 to M6 populations.
Population Day Morph Nr. of clones yrfF lon fusA yegh yiaW potA PotD folD trkH hipA wzc
M1 18 ANC 10 2 2 2 2
30 MUC 11 + 2 + +
30 ANC 10 2 2 2 2 2 2 2
M2 5 MUC 8 + 2 2
5 ANC 2 2 2 2
30 MUC 11 + 2 + 2 2 2
M3 18 ANC 10 2 2 2 2 2 2
18 MUC 6 + 2 + 2 2 2
18 MUC 2 + 2 + 2 2 2
18 MUC 2 + 2 2 2 2 2
30 MUC 7 + 2 2 2 2 2
30 MUC 2 + 2 + + 2 +
30 MUC 1 + 2 + 2 2 +
30 MUC 1 + 2 + + + +
M4 8 MUC 8 + 2 2 2
8 ANC 2 2 2 2 2
16 ANC 6 2 2 2 2
16 MUC 3 + 2 2 2
16 MUC 1 + 2 + 2
20 ANC 6 2 2 2
20 MUC 2 + + + +
20 MUC 2 + 2 2 2
30 MUC 2 + 2 2 2 2
30 MUC 1 + 2 2 + 2
30 MUC 8 + 2 2 + +
M5 8 ANC 10 2 2 2 2
14 ANC 4 2 2 2 2
14 MUC 6 + 2 2 2
18 ANC 10 2 2 2 2
20 ANC 6 2 2 2 2
20 MUC 4 + 2 2 2
30 MUC 1 + 2 2 2 2 2 + +
30 MUC 5 + 2 2 2 2 2 2 +
30 MUC 5 + 2 2 2 2 2 2 2
M6 18 ANC 10 2 2 2 2
26 ANC 6 2 2 2 2
26 MUC 2 2 2 2 2
26 MUC 2 + 2 + +
30 MUC 1 + 2 2 2 2
30 MUC 10 + 2 2 + +
doi:10.1371/journal.ppat.1003802.t002
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bacterial fitness, it is likely that the observed IS insertion
upstream of yrfF is an adaptive mutation with pleiotropic effects.
If so the adaptive path may proceed through the occurrence of
new mutations, which may compensate for the pleiotropic effects
of that first adaptive step. Interestingly, the same amino-acid
substitution in fusA occurred in two independent lines. FusA is an
elongation factor and is part of the str operon of E. coli, which has
3 other genes: rpsL, rpsG and tufA. Since the strain that we studied
carries a mutation in rpsL that confers streptomycin resistance,
which is costly in RPMI yet increases survival inside MW [59], it
is possible that the SNP in fusA could be compensatory to cost of
the rpsL mutation in the milleu outside MW.
One of the adaptive paths taken by E. coli included insertions
into the coding regions of yiaW and potA or potD. While the
function of yiaW is unknown, the later genes are involved in
spermidine transport, which may affect E. coli interaction with
MW. Spermidines are polyamines, polycationic molecules, which
interact with nucleic acids and have been described as important
in escape from phagolysosomes, biofilm formation and protection
from oxidative and acidic stress amongst other traits important in
bacterial pathogenesis [60].
The adaptive process was also marked by the occurrence of an
IS186 insertion into the promoter region of the Lon protease.
Such insertion was not only likely adaptive (it was observed in two
independent lineages and it increases mucoidy), but also likely
leads to increased rates of transposition. Given that many of the
adaptive mutations observed under the stresses imposed by MW
were caused by ISs, these may constitute an example of Barbara
McClintock proposal that transposable element movement under
stress could aid organisms to adapt to new environments [61].
The mechanisms via which different mutations underlying E.
coli pathoadaptation increase its virulence remain to be established.
It is likely however, that such mechanisms would interfere with
one or two host defense strategies against infections [62].
Presumably, by escaping MW killing pathoadaptation should
provide MUC clones with a proliferative advantage, ultimately
compromising host survival. This should be revealed by increased
bacterial burden in the MUC infected hosts, as compared to hosts
infected with non-evolved E. coli clones, revealing a compromise in
host resistance [62]. An alternative, but not mutually exclusive,
interpretation would be that pathoadaptation is associated with the
induction of a immunopathologic response compromising host
survival, irrespectively of pathogen burden. This should be
revealed by similar bacterial burdens in the MUC infected host,
as compared to hosts infected with non-evolved E. coli clones,
revealing a compromise in host disease tolerance [62]. While
critical to further understanding of the mechanism via which E. coli
pathoadaptation increases its virulence, this is beyond the scope of
the current study.
In conclusion, we demonstrate that E. coli can adapt to better
resist to MW within a few hundreds of generations and that clones
with different morphologies and traits similar to those of
pathogenic bacteria rapidly emerge. This pathoadaptive process
and the complex dynamics of the evolved phenotypes can be
reasonably described by a model of clonal interference, where
distinct haplotypes, carrying new transposon insertions and other
mutations, increase in frequency and compete for fixation.
Materials and Methods
Ethics statement
All experiments involving animals were approved by the
Institutional Ethics Committee at the Instituto Gulbenkian de
Cieˆncia (project nr. A009/2010 with approval date 2010/10/15),
following the Portuguese legislation (PORT 1005/92) which
complies with the European Directive 86/609/EEC of the
European Council.
Strains and media
The RAW 264.7 murine macrophage cell line was maintained in
an atmosphere containing 5% CO2 at 37uC in RPMI 1640 (Gibco)
supplemented with 2 mM L-glutamine (Invitrogen), 1 mM sodium
pyruvate (Invitrogen), 10 mM hepes (Invitrogen), 100 U/ml
penicillin/streptomycin (Gibco), 50 mM 2-mercaptoethanol solu-
tion (Gibco), 50 mg/ml gentamicin (Sigma), with 10% heat-
inactivated FCS (standard RPMI complete medium). Before
infection assays, MW were cultivated for 24 h in the same medium
as before except for the three antibiotics which were now replaced
by 100 mg/ml streptomycin antibiotic (RPMI-Strep medium). All
bacterial cultures were also done in RPMI-Strep medium, except if
stated otherwise.
The Escherichia coli strains used were MC4100-YFP and
MC4100-CFP (MC4100, galK::CFP/YFP, AmpRStrepR) which
contain the yellow (yfp) and cyan (cfp) alleles of GFP integrated at
Figure 5. Predictions of model of clonal interference for changes in mucoid frequencies with time. Simulations of the adaptive dynamics
over the period of the experiment (30 days). The frequencies of mucoid phenotypes are plotted and can be compared to those observed in the
experiments (Fig. 1B). The values of parameters used and the dynamics of haplotypes that compete for fixation are shown in Figure S9.
doi:10.1371/journal.ppat.1003802.g005
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the galK locus in MC4100 (E. coli Genetic Stock Center #6152)
and differ only by YFP/CFP locus that is constitutively expressed
[63]. MC4100-CFP strain was used for the evolution experiment
and MC4100-YFP as a reference strain for the fitness assays.
Evolution experiment
Twelve populations were founded from a single MC4100-CFP
clone and were therefore genetically uniform in the beginning of
the experiments. All populations evolved in RPMI, 6 populations
in the presence of the MW (M1–M6) and the other 6 (C1–C6) in
the absence of MW. Before each infection cycle, MW (0.76106 to
1.36106/ml) were centrifuged at 1200 rpm for 5 min, re-
suspended in RPMI-Strep medium and activated with 2 mg/ml
CpG-ODN 1826 (59TCCATGACGTTCCTGACGTT 39 -
Sigma) for 24 h [64]. Cells were then centrifuged (1000 rpm for
5 min), re-suspended in 3 ml of fresh RPMI-Strep medium and
seeded in 12-well microtiter plates (0.86106 to 1.66106/ml).
Subsequently, they were incubated at 37uC for 2 h, washed in
RPMI-Strep and infected with a MOI of 1:1 (106 bacteria to
106 MW). After 24 hours of infection, MW were detached with cell
scraper and the whole culture was centrifuged at 4000 rpm for
10 min to pellet cells. This procedure lyses MW releasing
intracellular bacteria. Then these were washed twice with
phosphate-buffered saline (PBS) and counted by flow cytometry
using a FACscan cytometer (Becton Dickinson). Approximately
106 of recovered bacteria were used to infect new activated MW in
the same manner as before. The same procedure was applied to
control populations, except that 104 bacteria were transferred
daily. This is because after 4 hours of infection with the MW
bacteria numbers drop to 104. This adjustment results in similar
number of generations in both environments. In both treatments
(with and without MW), bacteria were allowed to propagate for
approximately 15 generations per day. Generation time is
estimated as: G= log2(Nf/Ni), where Ni is the initial number of
bacteria and Nf is the final number of bacteria. Nf was
approximately 66108 in both treatments. Evolution occurred
during approximately 450 generations in both environments. We
note that in the context of a real infection repeated contact with
macrophages will not likely occur with a similar period as the one
in this experimental setup.
Fitness measurements
To estimate competitive fitness of M1–M6 populations, after
285 and 450 generations of evolution, each evolved population
was competed against MC4100-YFP reference strain in the same
conditions as used in the evolution experiment. Both evolved and
ancestral strains were grown separately in RPMI-Strep, 106 cells of
each type were used to inoculate the competition plate. The initial
and final ratios of both strains were determined by Flow
cytometry. The fitness of each population was measured 3 times
and the fitness of the ancestral strain 10 times to confirm the
neutrality of the marker. A measure of relative fitness increase,
expressed as selection coefficient, was estimated as:
Scoef f~
ln
Nf e=Nf a
 .
Nie=Nia
  
ln Nf a=Nia½ 
[65] where Scoeff is the selective advantage of the evolved strain e
over the ancestral strain a, Nfe and Nfa are the numbers of evolved
(e) and ancestral (a) bacteria after competition and Nia and Nie are
the initial numbers, before the competition.
Dynamics of infection at 3 h post infection
Bacterial uptake was measured by the gentamicin protection
assay as previously described [66], with modifications, as follows.
MW were infected at MOI 1:1 as described above to determine the
number of intracellular and extracellular bacteria after 3 h of
incubation. The number of extracellular bacteria at 3 h of
incubation was estimated by taking a sample of the culture
medium (without detaching the MW), centrifuging (4000 rpm for
10 min) to pellet the cells and finally washing these in PBS prior to
plating on LB agar plates. The number of intracellular bacteria
was estimated by washing infected MW twice with PBS and adding
fresh medium containing 100 mg of gentamicin/ml to kill
extracellular bacteria. After incubation for an additional hour,
the medium was removed, the monolayer of macrophages was
washed 3 times with PBS, detached using a cell scraper and
centrifuged (4000 rpm for 10 min) to pellet the cells. These were
further resuspended in PBS and the appropriate dilution was
plated on LB agar plates to determine the number of intracellular
bacteria. Relative abundance (Rr) of evolved clones to that of the
ancestral in intracellular or extracellular environment of MW was
estimated as:
Rr~ N3he=Nieð Þ= N3ha=Niað Þ,
where N3he and N3ha are the numbers of evolved (e) and ancestral
(a) bacteria at 3 hours post infection (in the intracellular or
extracellular niche of MW) and Nia and Nie are the initial numbers
of evolved (e) and ancestral (a) bacteria used for inoculation.
To measure numbers of MW that are alive, the same infection
protocol was performed. However, after 3 h of infection, MW were
washed from extracellular bacteria twice with RPMI, detached
and counted by Trypan blue exclusion test [67] (see Fig. S3).
Colanic acid purification and quantification
The method used to extract colanic acid was based on a
procedure described previously [68]. Briefly, 50 ml of a bacterial
cell culture was heated for 15 min at 100uC to denature EPS-
degrading enzymes, cooled down and centrifuged at 13200 rpm at
4uC for 30 min. Then 40 ml of the supernatant was precipitated
by addition of three volumes of ethanol. The mixture was
maintained at 4uC overnight and centrifuged again at 13200 rpm
at 4uC for 30 min. The resulting pellet was dissolved in 5 ml of
distilled water, dialyzed for 48 h against distilled water (membrane
MWCO, 3500 Da) and dried in SpeedVac. Residual polypeptides
were removed by precipitation with 5 ml of 10% (v/v) trichlor-
oacetic acid and centrifuged at 13200 rpm at 4uC for 30 min. The
supernatant was dialyzed for five days against distilled water and
dried. The resulting preparation was resuspended in 1 ml of
distilled water. Quantification of colanic acid was carried out by
measuring non-dialyzable methylpentose (6-deoxy-hexose), name-
ly fucose, which is a specific component of this exopolysaccharide.
10 to 100 ml of the colanic acid preparation were diluted to 1 ml
with distilled water, and mixed with 4.5 ml of H2SO4/H2O (6:1;
v/v). The mixture was prepared at room temperature, then heated
at 100uC for 20 min, and finally cooled down to room
temperature. For each sample, absorbance at 396 nm and
427 nm was measured either directly (control sample (A-co)) or
after addition of 100 ml of 0.3% freshly prepared cysteine
hydrochloride (cysteine sample (A-cy)). The absorption due to the
unspecific reaction with H2SO4 was subtracted from the total
absorption of the sample: A396-co and A427-co were subtracted from
A396-cy and A427-cy, respectively, to obtain DA396 and DA427.
Values of (DA396–DA427) were directly correlated to methylpentose
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concentration by using a standard curve obtained with a fucose
concentration ranging from 2 mg/ml to 100 mg/ml (Fig. S2).
SCV reversion rate and auxotrophy to hemin
To determine the reversion frequency of SCV to the ancestral
phenotype, single colonies grown on LB agar plates were
resuspended in PBS, the appropriate dilution was plated on LB
agar plates and incubated at 37uC. After 48 h small and large
colonies were counted [21]. To test for the auxotrophy to hemin,
individual SCV colonies were isolated, resuspended in PBS and
plated on M9 minimal medium agar plates containing 2% glucose
with and without hemin 50 mg/ml (Sigma-Aldrich). After incuba-
tion at 37uC for 48 h, CFUs were counted to estimate the ratio
between the number of cells able to grow in presence and in
absence of hemin.
Whole genome re-sequencing and mutation prediction
Both the ancestral and 7 isolated MUC clones (MUC3_d19
sampled from population M3 after 19 days of evolution with
macrophages and MUC1 to MUC6d30 sampled from M1 to M6
pops after 30 days of evolution) were grown overnight in 10 ml of
RPMI-Strep at 37uC. DNA isolation from these cultures was done
following a previously described protocol [69]. The DNA library
construction as well as the sequencing procedure was carried out
by BGI. Each sample was pair-end sequenced on an Illumina
HiSeq 2000. Standard procedures produced data sets of Illumina
paired-end 90 bp read pairs with insert size (including read length)
of ,470 bp.
Mutations in the two genomes were identified using the
BRESEQ pipeline [70]. To detect potential duplication events
we used SSAHA2 [71] and the paired-end information to map
reads only to their best-match on the genome. Sequence coverage
along the genome was assessed with a 250 bp window and
corrected for GC% composition by normalizing by the mean
coverage of regions with the same GC%. We then looked for
regions with high differences (.1.4) in coverage. We did not find
any such difference between the ancestral and evolved clones. See
Table 2 for the identity and precise location of mutations identified
in the sequenced clones. All mutations were confirmed by direct
target sequencing.
Detection of mutations
In order to determine the frequency of the mutations in clones
sampled along the experiment, DNA was amplified by PCR (to
identify IS insertions) and sequencing PCRwas performed (to identify
SNPs). DNA was amplified by PCR in a total volume of 50 ml
containing 1 ml bacterial culture, 10 mM of each primer, 200 mM
dNTPs, 0.5 U Taq polymerase and 16Taq polymerase buffer. The
amplification profile was 15 min at 95uC, followed by 35 cycles at
94uC for 30 s, 60uC for 90 s, 72uC for 2 min with a final extension at
72uC for 10 min. All gene fragments were amplified using these
conditions and oligonucleotide primers (Table S2). The same primers
were used for sequencing straight from the PCR product.
In-vivo virulence tests of ancestral and evolved bacteria
We maintained male C57/BL6 mice, aged 8–10 weeks (in
house supplier, Instituto Gulbenkian de Cieˆncia), on ad libitum food
(RM3A(P); Special Diet Services, UK) and water, with a 12 hour
light cycle, at 21uC. We initiated infections by intra-peritoneal
inoculation of bacteria in 100 ml saline. Several groups of mice
were injected with different bacterial strains at doses ranging from
26105 to 36108 (sample sizes: ancestral – n= 46; control – n= 41,
mucoid – n= 50). At doses 16107, 56107 and 16108, we injected
a minimum of 10 mice, in at least two independent experiments
(data from the same animals was used for the Kaplan-Meier curves
in Fig. 3C). The inocula consisted of the following: a single clone
for ancestral bacteria (ANC), consisted of a mixture of equal
numbers of the 6 sequenced clones from day 30 (MUC1-MUC6;
see Fig. 4) for the mucoids (MUC) and mixture of 6 independent
clones evolved in the absence of macrophages (CON). Further-
more, as a control, in each experimental block we injected a group
of 2–3 mice with 100 ml of saline (these animals did not display any
signs of disease). We monitored mice for a period of 6–10 days
(twice a day for the first two days and daily for the remaining 8
days) and measured weight and temperature.
To estimate the LD50 values (Fig. 3A–B,E), we fitted a binomial
generalized linear model (GLM) for each morphotype, using
survival as a response variable and log10 bacterial dose as
explanatory variable (following [72]). To analyze the temporal
dynamics of mortality in mice infected with MUC or ANC at the
MUC LD50 (Fig. 3C), we used Kaplan-Meier curves followed by a
log-rank test. Finally, we used GLMs to test whether the variation
maximum reduction in temperature or weight could be explained
by the infecting strain.
Statistical analysis
The statistical analysis was performed using the R software:
http://www.r-project.org/.
Supporting Information
Figure S1 Infection dynamics of the ancestral strain.
Variation in numbers of bacteria (A) and MW (B) during an
infection with the ancestral clone (ANC) at MOI (1:1). (C)
Simulated dynamics of a population of ancestral bacteria dividing
in the presence of MW for 24 hours, following the deterministic
model dBdt ~B r{
B
K{amMWe
{dt
 
(see Text S1), with the
following parameter values: B0 = 10
6; MW=10
6; r=2.3; K=108;
am=23.7*10
26; d=0.1. We assume that MW decay at linear rate
of 0.1 following the data of (B).
(TIF)
Figure S2 Calibration curve for quantification of cola-
nic acid in evolved clones. Empty circles represent three
replicate measurements and filled circles their average.
(TIF)
Figure S3 Comparison of MUC and ANC clones in the
presence of MW. (A) Numbers of alive MW after 3 h of infection
with evolved MUC clones versus ANC clone. (B) MUC clones
survive inside MW similarly to ANC clone: in the Y-axis it is shown
the percentage of alive bacteria after 24 hours of internalization.
(C) MUC clones do not impair MW ability to engulf ANC bacteria.
Co-infection was performed with ANC and MUC clones (a pool of
six sequenced MUC1 to MUC6 clones at equal frequencies). Black
bars represent bacteria used for initial inoculation (0 h) and grey
bars – bacteria recovered intracellularly after 3 h of infection (3 h).
Error bars correspond to 2SE.
(TIF)
Figure S4 Levels of the pro-inflammatory cytokine TNF.
The level of TNF detected after 4 hours of MW infection with
ANC, CON and MUC bacteria at MOI= 0.01. Means of 3
independent experiments are shown with error bars corresponding
to SEM. NI- not infected macrophages.
(TIF)
Figure S5 Growth of evolved clones in the presence of
polyamines. The ratio between carrying capacity (K) in the
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presence and absence of spermidine (A) or spermine (B) after
24 hours of growth indicate differential survival in the presence of
polyamines. MUC1 to MUC6 correspond to MUC_M1_D30 to
MUC_M6_D30 clones and MUC3* corresponds to MUC_M3_
D19 clone. Error bars correspond to 2SE.
(TIF)
Figure S6 Estimation of mutation frequency of ances-
tral strain (ANC) in the presence and in the absence of
MW. There was no difference in the frequency of nitrofuran-
resistant clones in the presence versus absence of MW (median
frequency 5.2561026 vs. 4.3561026, P= 0.49, W=78, Mann-
Whitney U test), as well as there was no difference in the insertion
frequency (with MW IS frequency was 52% (51 out of 98 sampled
clones), without MW IS frequency was 59% (50 out of 85 sampled
clones)).
(TIF)
Figure S7 Variation in exopolysaccharide production
among evolved clones. Amount of EPS per bacterial cell was
measured for the ancestral strain (ANC) and six mucoid clones
that evolved independently (MUC1 to MUC6): we also measured
the amount of EPS in MUC_M3_D19 (MUC3*) and in six other
clones derived from this clone after a growth in RPMI (T136–
T138, T122–T124). None of these derived clones have the IS186
insertion in lon promoter region and all have the IS1 insertion
upstream of yrfF. T136–T138 are visibly mucoid and T122–T124
show a non-mucoid colony morphology. All measurements were
done in triplicate.
(TIF)
Figure S8 Relative abundance of evolved clones in the
presence of MW. Relative abundance (Rr) of MUC_M3_D19
(MUC) clone and six clones derived from this clone (T122–T124
non-mucoid and T136–T138 mucoid clones) are represented
either inside MW (black bars) or outside MW (white bars).
(TIFF)
Figure S9 Dynamics for the different haplotypes under
the model of clonal interference. Simulated frequencies of
the different haplotypes which result in the frequencies of the
mucoid phenotypes of Figure 5. r=2.3, am =23.761026 and the
other parameters used are shown in Table S3. In this table, the
cases where more haplotypes were assumed to reproduce the
experimental dynamics are marked with *, and the additional
parameters are in Table S4.
(TIFF)
Figure S10 Region of parameter space theoretically
expected for the invasion of first mucoid morph. Colored
areas show the parameter region (rm/r and ammuc/am) where a
mucoid genotype (mimicking the IS insertion upstream of yrfF in
the experiment) that has emerged is able to increase in frequency
so that it can survive the bottleneck imposed every 24 hours in the
experiment. The equations for these simulations are:
dB
dt
~B r{
BzMucð Þ
K
{amMWe
{dt
 	
dMuc
dt
~Muc rm{
BzMucð Þ
K
{ammucMWe
{dt
 	
with initial conditions Muc(0) = 1, B(0) = 106 and the other
parameter values as in Figure S1: MW=10
6; r=2.3; K=108;
am=3.7*10
26; d=0.1. Note that the escape parameter is negative
(according to the mathematical model) and, therefore, a value
lower than 1 indicates a higher ability to escape predation.
Warmer colors show higher frequency of the mucoid genotype in
the population after 24 hours of its emergence as a single copy.
The black dot indicates the value of rm and ammuc, of the first
mucoid haplotype assumed to emerge in the 6 models that
produced the dynamics in Figures 5 and S8.
(TIFF)
Figure S11 Relative growth rate for clones with an
ancestral colony morphology (non-mucoid). Multiple clones
were randomly isolated from two populations at different time points,
as indicated in the x-axis, below the clone numbers. Replicate
measures for the maximum growth rate of each clone were obtained
from independent cultures and divided by the mean growth rate of
the original ancestral. The ancestral for the main experiment (ANC)
is highlighted in red, the evolved clones whose growth rate is
significantly different from the ancestral are highlighted in blue
(P,0.05, ANOVA; white: not significantly different from ANC).
ANC: 16 replicates; evolved clones: 3–4 replicates.
(TIFF)
Figure S12 Fluctuation test of evolved MUC clone
(MUC_M3_D19) and ANC clone to test for increase in
mutagenesis. Black squares (for MUC clone) and white squares
(for ANC clone) each represent 50 independent measurements of
the frequency of spontaneous mutants resistant to d-cycloserine.
Mutation rates were significantly higher in the MUC compared
with the ANC clone (median MUC=2.661026 and ANC=16
1027, P= 5.5610213, W=203.5, Mann-Whitney U test).
(TIFF)
Protocol S1 Full script for the model of clonal interfer-
ence obtained in Mathematica v8.0.
(PDF)
Table S1 Increased resistance of the SCV clone to
aminoglycoside antibiotics. Minimal inhibitory concentra-
tion (MIC) of each clone was measured in triplicate by a disc
diffusion assay. S indicates sensitive clones and R resistant clones.
SCV_M1_D8, SCV_M2_D4, SCV_M3_D5 and MUC_M2_
D19, MUC_M3_D19, MUC_M4_D19 clones are shown.
(DOC)
Table S2 Primers used in this study.
(DOC)
Table S3 Parameters used in modeling the dynamics of
the different haplotypes. Parameters used for the dynamics in
figure S9. Cases where more haplotypes were assumed to
reproduce the experimental dynamics are marked with *, and
the additional parameters are in Table S4.
(DOC)
Table S4 Parameters for the additional haplotypes for
the modeled dynamics. Parameters in the additional haplo-
types required to obtain the dynamics in Figure S9.
(DOC)
Text S1 Includes Model of Clonal interference, Supple-
mentary Materials and Methods and Supplementary
References.
(DOC)
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